Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Evandro de Azambuja
Based on 85 articles published since 2008
||||
Expertise Level
The expertise of Evandro de Azambuja ranks in the
  • Top 0.016%
  • ... of 257,180 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 85 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases de Azambuja, E   ·   de Azambuja, Evandro   ·   De Azambuja, Evandro   ·   De Azambuja, E
Work Locations
Details
Most likely:    Jules Bordet Institute      
2018
  • Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Pubmed 29307195
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Molecular Immunology Unit, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 28185173
  • a BrEAST Data Centre, Institut Jules Bordet , l'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium. · b Breast Cancer Translational Research Laboratory , Institut Jules Bordet , Brussels , Belgium. · c Molecular Immunology Unit , Institut Jules Bordet , Brussels , Belgium. · Pubmed 27883296
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Department of Medical and Biological Sciences, University of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven-University of Leuven, B-3000 Leuven, Belgium. · Department of Pathology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of General Medical Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Gynecology and Obstetrics, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Pubmed 27802449
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 26654400
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Ciara C. O'Sullivan and Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Ian Bradbury, Christine Campbell, and Eileen Holmes, Frontier Science, Inverness-shire, Scotland · Marc Spielmann and Suzette Delaloge, Institut de Cancérologie Gustave Roussy, Villejuif, France · Edith A. Perez, Mayo Clinic, Jacksonville, FL · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Joseph P. Costantino and Priya Rastogi, University of Pittsburgh, Pittsburgh, PA · Dimitrios Zardavas, Breast International Group · Karla V. Ballman, Mayo Clinic, Rochester, MN · Evandro de Azambuja and Martine Piccart-Gebhart, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium · and Richard D. Gelber, Harvard Medical School, Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 26101239
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 25156453
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Department of Medical Oncology, Institut Jules Bordet, Brussels. · Data Centre, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Brussels · Pubmed 24562450
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2010
  • Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 19731015
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2013
  • Medical Oncology Department, Institut Jules Bordet, Br.E.A.S.T. Data Centre Brussels, Blvd de Waterloo, 121 (7th Floor), 1000 Brussels, Belgium. · Pubmed 24138446
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium · Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22910839
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Institut Jules Bordet, l'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23014186
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 22713170
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
  • Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 22367645
2011
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21918439
  • Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 21342046
  • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 21289366
  • Medical Oncology Clinic, Jules Bordet Institute, Brussels 1000, Belgium. · Pubmed 22043056
  • Breast Cancer Translational Research Laboratory JC Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 125 Bld de Waterloo, 1000 Brussels, Belgium. · Pubmed 21422418
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
2010
  • Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000, Brussels, Belgium. · Pubmed 20004109
Probable:    Universite Libre de Bruxelles      
2018
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2010
  • Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 19731015
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium · Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 22713170
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
2011
  • Breast Cancer Translational Research Laboratory JC Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 125 Bld de Waterloo, 1000 Brussels, Belgium. · Pubmed 21422418
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
2010
  • Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000, Brussels, Belgium. · Pubmed 20004109
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 85 total) written by Evandro de Azambuja about Breast Neoplasms:

  • Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patients. 2018
  • Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis. 2018
  • p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. 2018
  • Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer. 2018
  • The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. 2018
  • HER2-positive breast cancer is lost in translation: time for patient-centered research. 2017
  • Breast cancer treatment-induced cardiotoxicity. 2017
  • Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials. 2017
  • Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer. 2017
  • Adjuvant trastuzumab: a 10-year overview of its benefit. 2017
Show List of Full Article Records
Google Searches

Learn more about Evandro de Azambuja using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Jules Bordet Institute
Universite Libre de Bruxelles
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Jules Bordet Institute
2018
  • Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Pubmed 29307195
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Molecular Immunology Unit, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 28185173
  • a BrEAST Data Centre, Institut Jules Bordet , l'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium. · b Breast Cancer Translational Research Laboratory , Institut Jules Bordet , Brussels , Belgium. · c Molecular Immunology Unit , Institut Jules Bordet , Brussels , Belgium. · Pubmed 27883296
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Department of Medical and Biological Sciences, University of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven-University of Leuven, B-3000 Leuven, Belgium. · Department of Pathology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of General Medical Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Gynecology and Obstetrics, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Pubmed 27802449
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 26654400
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Ciara C. O'Sullivan and Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Ian Bradbury, Christine Campbell, and Eileen Holmes, Frontier Science, Inverness-shire, Scotland · Marc Spielmann and Suzette Delaloge, Institut de Cancérologie Gustave Roussy, Villejuif, France · Edith A. Perez, Mayo Clinic, Jacksonville, FL · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Joseph P. Costantino and Priya Rastogi, University of Pittsburgh, Pittsburgh, PA · Dimitrios Zardavas, Breast International Group · Karla V. Ballman, Mayo Clinic, Rochester, MN · Evandro de Azambuja and Martine Piccart-Gebhart, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium · and Richard D. Gelber, Harvard Medical School, Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 26101239
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 25156453
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Department of Medical Oncology, Institut Jules Bordet, Brussels. · Data Centre, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Brussels · Pubmed 24562450
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2010
  • Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 19731015
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2013
  • Medical Oncology Department, Institut Jules Bordet, Br.E.A.S.T. Data Centre Brussels, Blvd de Waterloo, 121 (7th Floor), 1000 Brussels, Belgium. · Pubmed 24138446
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium · Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22910839
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Institut Jules Bordet, l'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23014186
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 22713170
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
  • Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 22367645
2011
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21918439
  • Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Pubmed 21342046
  • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 21289366
  • Medical Oncology Clinic, Jules Bordet Institute, Brussels 1000, Belgium. · Pubmed 22043056
  • Breast Cancer Translational Research Laboratory JC Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 125 Bld de Waterloo, 1000 Brussels, Belgium. · Pubmed 21422418
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
2010
  • Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000, Brussels, Belgium. · Pubmed 20004109
Universite Libre de Bruxelles
2018
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
2017
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2010
  • Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 19731015
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium · Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23169515
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 22713170
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
2011
  • Breast Cancer Translational Research Laboratory JC Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 125 Bld de Waterloo, 1000 Brussels, Belgium. · Pubmed 21422418
  • Department of Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, 1000 Brussels, Belgium. · Pubmed 21354372
2010
  • Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000, Brussels, Belgium. · Pubmed 20004109
Unspecified
2014
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet · Evandro de Azambuja, Breast European Adjuvant Study Team · Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie · David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh · Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research · Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom · Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands · Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA · Jutta Steinseifer, F. Hoffmann-La Roche, Basel · Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland · Michael Untch, HELIOS Klinikum Berlin, Buch · Christian Jackisch, Klinikum Offenbach, Offenbach, Germany · Luca Gianni, San Raffaele Institute, Milan, Italy · Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia · and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
44 Other Locations Show
Yearly article counts 51299102079400
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.